Devyser Diagnostics AB Cash Flow-to-Debt Ratio
Devyser Diagnostics AB cash flow-to-debt ratio. Devyser Diagnostics AB (DVYSR) has a Cash Flow-to-Debt Ratio of 0.11x as of June 2026, meaning its operating cash flow of Skr12.30 Million could theoretically repay 0% of its total liabilities (Skr112.10 Million) in one year. Check DVYSR operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Devyser Diagnostics AB (2018–2025)
Cash flow-to-debt ratio of Devyser Diagnostics AB from 2018 to 2025. Historical debt coverage capacity for Devyser Diagnostics AB across 8 annual periods. Check DVYSR capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Devyser Diagnostics AB Cash Flow-to-Debt Ratio by Year (2018–2025)
Devyser Diagnostics AB cash flow-to-debt ratio by year from 2018 to 2025. Year-by-year debt coverage analysis for Devyser Diagnostics AB. For the full cash flow conversion analysis, see Devyser Diagnostics AB cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | Skr8.20 Million | Skr115.40 Million | ▲ +118.9% |
| 2024 | -0.38x | Skr-46.80 Million | Skr124.80 Million | ▲ +32.7% |
| 2023 | -0.56x | Skr-69.70 Million | Skr125.00 Million | ▲ +4.7% |
| 2022 | -0.59x | Skr-40.50 Million | Skr69.19 Million | ▼ -42.7% |
| 2021 | -0.41x | Skr-16.48 Million | Skr40.18 Million | ▼ -2951.1% |
| 2020 | 0.01x | Skr627.00K | Skr43.58 Million | ▼ -96.4% |
| 2019 | 0.40x | Skr14.63 Million | Skr36.69 Million | ▲ +20.9% |
| 2018 | 0.33x | Skr6.02 Million | Skr18.25 Million | — |